Evo Fund lowers stake in Oncolys BioPharma to 5.24%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-22 15:28 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 5.24%, previous report: 6.78%.